Laddar...
A robust prognostic gene expression signature for early stage lung adenocarcinoma
BACKGROUND: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients would be critical to identify those most likely to benefit from early addition...
Sparad:
| I publikationen: | Biomark Res |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761211/ https://ncbi.nlm.nih.gov/pubmed/26900477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-016-0058-3 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|